Progressive supranuclear palsy: diagnosis and management
- PMID: 34215700
- PMCID: PMC8461411
- DOI: 10.1136/practneurol-2020-002794
Progressive supranuclear palsy: diagnosis and management
Abstract
Treating patients with progressive supranuclear palsy (PSP) is both effective and rewarding. This review aims to share our experience in the proactive management of PSP, considering the patient, the family and the medical context in which the illness unfolds. There are many opportunities to assist your patients, ameliorate their symptoms, reduce their risks and harm, and guide them through the complex medical, social and legal minefield that characterises life with chronic neurological illness. We summarise the challenges of early diagnosis, consider PSP mimics and the role of investigations in excluding these, and discuss the available pharmacological and non-pharmacological treatment strategies to tackle the common and challenging symptoms of PSP. The best treatment will be patient centred and as part of a multidisciplinary team.
Keywords: cognition; dementia; movement disorders; supranuclear palsy.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


References
-
- Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333–59. 10.1001/archneur.1964.00460160003001 - DOI - PubMed
-
- Imaging and atypical parkinsonism - ACNR | Paper & Online Neurology Journal ACNR | Paper & Online Neurology Journal. Available: https://www.acnr.co.uk/2015/01/imaging-and-atypical-parkinsonism/ [Accessed 11 Jan 2021].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous